1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE
中文名称 | 1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE |
---|---|
中文同义词 | 化合物ITSA1;(1H-苯并[D][1,2,3]三唑-1-基)(2,4-二氯苯基)甲酮;ITSA-1,HDAC激活剂 |
英文名称 | BENZOTRIAZOL-1-YL-(2,4-DICHLORO-PHENYL)-METHANONE |
英文同义词 | IFLAB-BB F0451-3184;BENZOTRIAZOL-1-YL-(2,4-DICHLORO-PHENYL)-METHANONE;1-(2,4-Dichlorobenzoyl)-1H-benzotriazole;ITSA-1(ITSA1);CS-2249;Methanone, 1H-benzotriazol-1-yl(2,4-dichlorophenyl)-;(1H-Benzo[d][1,2,3]triazol-1-yl)(2,4-dichlorophenyl)methanone;inhibit,Histone deacetylases,ITSA-1,Inhibitor,HDAC,ITSA 1 |
CAS号 | 200626-61-5 |
分子式 | C13H7Cl2N3O |
分子量 | 292.12 |
EINECS号 | |
相关类别 | 活性小分子库;标准品 |
Mol文件 | 200626-61-5.mol |
结构式 |
1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE 性质
熔点 | 119-121°C |
---|---|
储存条件 | Inert atmosphere,2-8°C |
溶解度 | 二甲基亚砜:28mg/mL |
形态 | 固体 |
颜色 | 白色至类白色 |
HDAC
|
ITSA1 (50 μM; A549 cells) treatment serves to revert the TSA-arrested population to a normal cell cycle distribution. ITSA1 is also able to effect cell cycle rescue over longer duration.
ITSA1 (50 μM; 5 hours; A549 cells) treatment reduces the number of apoptosis in TSA-treated cells.
ITSA1 (50 μM; 2 hours; A549 and murine ES cells cells) treatment suppresses TSA-induced histone acetylation. Importantly, suppression of acetylation levels is only observable when ITSA1 is added concurrent with or post TSA treatment.
ITSA1 (50 μM; 30 minutes; murine ES cells cells) suppresses TSA-activated transcription in murine ES cells.
Cell Cycle Analysis
Cell Line: | Murine ES cells |
Concentration: | 50 μM |
Incubation Time: | |
Result: | Served to revert the TSA-arrested population to a normal cell cycle distribution. |
Apoptosis Analysis
Cell Line: | A549 cells |
Concentration: | 50 μM |
Incubation Time: | 5 hours |
Result: | Reduced the number of apoptosis. |
Western Blot Analysis
Cell Line: | A549 and murine ES cells |
Concentration: | 50 μM |
Incubation Time: | 2 hours |
Result: | Reduced histone acetylation to the baseline level. |
RT-PCR
Cell Line: | Murine ES cells |
Concentration: | 50 μM |
Incubation Time: | 30 minutes |
Result: | Suppressed TSA-activated transcription. |
ITSA-1 (0.5 mg/kg; intraperitoneal injection; 3 times/week; for 8 weeks; CBS +/− mice) treatment balances deacetylation activity and suppresses IL-6 and TNF-α expression and thereby attenuated histone acetylationdependent infammatory signaling.
Animal Model: | CBS +/− mice |
Dosage: | 0.5 mg/kg |
Administration: | Intraperitoneal injection; 3 times/week; for 8 weeks |
Result: | Balanced deacetylation activity and suppressed IL-6 and TNF-α expression. |